➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
Merck
McKesson
Dow

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Sodium fluoride f-18 - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for sodium fluoride f-18 and what is the scope of freedom to operate?

Sodium fluoride f-18 is the generic ingredient in three branded drugs marketed by Ge Healthcare, Nih Nci Dctd, 3d Imaging Drug, Biomedcl Res Fdn, Cardinal Health 414, Decatur, Essential Isotopes, Hot Shots Nm Llc, Jubilant Draximage, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, The Feinstein Inst, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Tx Md Anderson, and Univ Utah Cyclotron, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and seventy-two drug master file entries for sodium fluoride f-18. Sixteen suppliers are listed for this compound.

Summary for sodium fluoride f-18
Recent Clinical Trials for sodium fluoride f-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of New EnglandEarly Phase 1
University of BaghdadPhase 2/Phase 3
Dow University of Health SciencesPhase 3

See all sodium fluoride f-18 clinical trials

Pharmacology for sodium fluoride f-18
Medical Subject Heading (MeSH) Categories for sodium fluoride f-18

US Patents and Regulatory Information for sodium fluoride f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hot Shots Nm Llc SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204530-001 Jul 29, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Sofie SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203592-001 Aug 18, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Essential Isotopes SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204541-001 Oct 29, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Ge Healthcare FLUORINE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 017042-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
3d Imaging Drug SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203777-001 Oct 19, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
Merck
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.